title: Heparin resistance during membrane plasmapheresis.
authors.affiliation: Cleveland Clinic Foundation, One Clinic Center, Ohio 44195-5132.
authors.forename: M
authors.initials: M
authors.lastname: Yamashita
authors.forename: S
authors.initials: S
authors.lastname: Omokawa
authors.forename: F V
authors.initials: FV
authors.lastname: Lucas
authors.forename: Y
authors.initials: Y
authors.lastname: Takeyama
authors.forename: J B
authors.initials: JB
authors.lastname: Goldcamp
authors.forename: A P
authors.initials: AP
authors.lastname: Koo
authors.forename: P S
authors.initials: PS
authors.lastname: Malchesky
authors.forename: Y
authors.initials: Y
authors.lastname: Nosè
mesh_terms: D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000628:therapy; D001777:Blood Coagulation / Q000187:drug effects; D003449:Cryoglobulinemia / Q000097:blood / Q000628:therapy; D004351:Drug Resistance; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis / Q000009:adverse effects* / Q000379:methods
chemical_list: D006493:Heparin